AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker ...

AstraZeneca (AZN) announced an investment of $2.5B in Beijing to establish its sixth global strategic R&D center together with major ...

AstraZeneca (AZN) said Friday it plans to invest $2.5 billion in a new research and development hub in China as the drugmaker tries to reignite ...

AstraZeneca to buy EsoBiotec for up to $1 billion Deal aims to enhance cancer cell therapy capabilities AstraZeneca secures global rights to Alteogen's ALT-B4 enzyme AstraZeneca shares up almost ...

AstraZeneca bought Belgian biotech company EsoBiotec in a deal valued at up to $1 billion, to expand its cell-therapy portfolio. The British pharma company said Monday that it will pay $425 ...

AstraZeneca is hopping aboard the pickleball craze as its serves up a new marketing push for its asthma med Fasenra. The injectable drug will serve as an official partner of the Professional ...

AstraZeneca has advanced its push to make camizestrant a blockbuster, reporting a phase 3 win for the oral SERD at an interim analysis. The trial hit on progression-free survival (PFS), its ...

Since the GBS outbreak, 153 have been treated and discharged, 32 are in ICU and 18 on ventilator support, said the state health officials With two suspected Guillain-Barré Syndrome (GBS ...

Guillain-Barré Syndrome (GBS) is an uncommon but deadly disorder in which the immune system attacks the nerves, causing muscular weakness and sometimes paralysis. Recently, the National Institute ...

(Reuters) -Drugmaker AstraZeneca has agreed to buy Belgium-based biotechnology firm EsoBiotec for up to $1 billion, it said on Monday, seeking to accelerate the development of its cell therapy ...

This is particularly beneficial for individuals with Guillain-Barré Syndrome (GBS), as the regulation of T helper cell subsets by probiotics can help alleviate symptoms associated with the ...

Doctors in Pune observed fast progression and increased cases of Guillain-Barre Syndrome (GBS). Some patients showed rapid recovery while others had high fatalities. Specialists reported cases ...